期刊文献+

难治性溃疡性结肠炎患者临床诊断与治疗研究 被引量:9

Clinical diagnosis and treatment in patients with refractory ulcerative colitis
原文传递
导出
摘要 目的探讨难治性溃疡性结肠炎患者的临床诊断、治疗方法及治疗效果。方法将广东省东莞市企石医院消化内科收治的86例难治性溃疡性结肠炎患者,随机分为对照组(n=43)和观察组(n=43),对照组采用柳氮磺胺吡啶联合奥沙拉嗪治疗,观察组在对照组的基础上加用中药保留灌肠治疗。比较两组治疗前后主要临床症状改善情况、不良反应发生情况及导致难治的原因等,参考陈先社等的相关标准分析比较两组治疗效果。结果对照组总有效率81.4%;观察组总有效率97.7%。观察组显效率及总有效率显著高于对照组,差异有统计学意义(χ2=12.35,P<0.05)。观察组与对照组治疗前脓血便、腹痛、腹泻、腹胀、里急后重等临床症状积分比较,差异无统计学意义(t=2.920,P>0.05)。观察组治疗后脓血便、腹痛、腹泻、腹胀、里急后重等临床症状积分显著低于对照组,差异有统计学意义(t=4.303,P<0.05)。观察组不良反应发生率显著低于对照组,差异有统计学意义(χ2=5.99,P<0.05)。难治原因为:担心药物不良反应而中断治疗;经济因素;出院后无法坚持用药;患者认识偏差;治疗方案单一。结论采用中西医结合治疗难治性溃疡性结肠炎,治疗效果优于西医治疗,不良反应少,临床症状改善显著,值得临床推广应用。 Objective To explore the clinical diagnosis and treatment methods and therapeutic effect of patients with refractory ulcerative colitis. Methods Eighty-six cases of patients with refractory ulcerative colitis in department of gimedicine,Qishi people's Hospital of Dongguan in Guangdong Province were randomly divided into control group and observation group. The control group used willow nitrogen-pyridine with salad clomipramine treatment, the observation group added traditional Chinese medicine. Then the curative effect,main clinical symptoms adverse reaction and the cause of the two groups were analysed. Results The total efficiency of the control group was 81. 4%,the observation group' s was 97. 7%. The observation group showed that the efficiency and the total effective rate were significantly higher than the control group,the difference had statistical significance( χ2= 12. 35,P < 0. 05). The purulent blood,abdominal pain,diarrhea,abdominal distension,tenesmus symptoms integral of the two groups before treatment were compared and there was no statistically significant difference( t = 2. 920,P > 0. 05). The purulent blood, abdominal pain, diarrhea, abdominal distension, tenesmus symptoms integral of the observation group after treatment was significantly lower than the control group' s,and the difference had statistical significance( t = 4. 303,P < 0. 05). The incidence of adverse of the observation group was significantly lower than control group,the difference has statistical significance( χ2= 5. 99,P < 0. 05). Is reason to worry about: drug side effects and interruption of treatment,economic factors,being unble to adhere to the drug treatment after discharge from hospital,patients understanding deviation,a single treatment. Conclusion That traditional Chinese and western medicine integrated is better than western medicine in treatment of refractory ulcerative colitis,treatment effect,less adverse reaction,the clinical symptoms improved significantly,worthy of clinical application.
出处 《中华损伤与修复杂志(电子版)》 CAS 2013年第6期29-31,38,共4页 Chinese Journal of Injury Repair and Wound Healing(Electronic Edition)
基金 东莞市科技局科技项目(201210515012128)
关键词 难治性溃疡性结肠炎 诊断 治疗 Refractory ulcerative colitis Diagnosis Treatment
  • 相关文献

参考文献9

  • 1曹倩,薛猛,雷敏.234例难治性溃疡性结肠炎患者临床特征及治疗分析[J].中华消化杂志,2011,31(9):577-581. 被引量:31
  • 2Fite A,Macfarlane S,Furrie E. Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration[J].{H}Journal of Clinical Microbiology,2013,(03):849856.
  • 3Husain N,Tokoro K,Popov JM. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis[J].{H}Journal of Clinical Gastroenterology,2013,(03):246-251.
  • 4陈先社,张晓林,郭联斌.巴柳氮钠联合康复新液治疗溃疡性结肠炎的临床疗效观察[J].成都医学院学报,2012,7(3):454-456. 被引量:8
  • 5Bennebroek Evertsz' F,Nieuwkerk PT,Stokkers PC. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission:a comparison of the P-SCCAI with clinician-based SCCAI and biological markers[J].J Crohns Colitis,2013,(11):890-900.
  • 6于蕾.溃疡性结肠炎临床120例疗效观察[J].中国现代药物应用,2012,6(22):23-24. 被引量:3
  • 7Gomollón F,García-López S,Sicilia B. Therapeutic guidelines on ulcerative colitis:a GRADE methodology based effort of GETECCU[J].{H}Gastroenterologia y Hepatologia,2013,(02):104-114.
  • 8王纪东.中西医结合治疗难治性溃疡性结肠炎55例临床观察[J].中国实用医药,2012,7(3):189-190. 被引量:11
  • 9Bessissow T,Bisschops R. Advanced endoscopic imaging for dysplasia surveillance in ulcerative colitis[J].Expert Rev Gastroenterol Heoatol,2013,(01):57-67.

二级参考文献32

  • 1向军英,冯迎春.美常安联合柳氮磺吡啶治疗溃疡性结肠炎22例[J].世界华人消化杂志,2006,14(17):1742-1744. 被引量:19
  • 2兰平.应该进行系统的中国炎症性肠病临床与实验研究[J].中华胃肠外科杂志,2007,10(3):202-203. 被引量:8
  • 3木村伊佐美 永滨忍 川崎真规.巴柳氮的药理学研究[J].日药理志,1997,109(2):85-94.
  • 4Moss AC, Peppercorn MA. Steroid-refractory ulcerative colitis: what are the available treatment options? Drugs, 2008,68:1157-1167.
  • 5Kievit W, Hendrikx J, Stalmeier PF, et al. The relationship between change in suhjective outcome and change in disease: a potential paradox. Qual Life Res, 2010,19:985-994.
  • 6Ogata H, Matsui T, Nakamura M, et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut, 2006, 55: 1255-1262.
  • 7Fujishima S, Takeda H, Kawata S, et al. The relationship between the expression of the glueocorticoid receptor in biopsied colonic mucosa and the glucocortieoid responsiveness of ulcerative colitis patients. Clin Immunol, 2009, 133: 208-217.
  • 8Honda M, Orii F, Ayabe T, et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology, 2000,118:859-866.
  • 9Farrell RJ, Murphy A, Long A, et al. High multidrug resistance (P-glyeoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology, 2000,118:279 288.
  • 10Creed TJ, Probert CS. Review article: steroid resistance in inflammatory bowel disease-mechanisms and therapeutic strategies. Aliment Pharmacol Ther, 2007,25 :111- 122.

共引文献48

同被引文献66

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部